Who is sponsoring NCT04676074?

NCT04676074 is sponsored by Cairo University.

What drugs are being tested in NCT04676074?

Interventions in NCT04676074: Electronic Upper limb( body) ergometer.

What condition does NCT04676074 study?

NCT04676074 studies Post Menopausal Obese Women.

Is NCT04676074 still recruiting?

NCT04676074 is currently completed. Last updated 8 June 2021.

Last reviewed 2021-06-08 · How we verify

NCT04676074

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Upper Limb Ergometer on the AIP in Post Menopausal Obese Women.

Completed NA Last updated 8 June 2021

What this trial tests

NA trial testing Electronic Upper limb( body) ergometer in Post Menopausal Obese Women in 40 participants. Completed in 31 March 2021.

Timeline

15 November 2020

Primary endpoint
15 February 2021

31 March 2021

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	15 November 2020
Primary completion	15 February 2021
Estimated completion	31 March 2021
Sites	1 location across Egypt

Drugs / interventions tested

Electronic Upper limb( body) ergometer

Conditions studied

Post Menopausal Obese Women — all drugs for Post Menopausal Obese Women →

Sponsor

Cairo University

Who can join

Adults 45 to 60, female only, with Post Menopausal Obese Women. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants had randomly divided into two equal groups. Group (A) which is the control group receive normal routine medication. Group (B) will receive normal routine medication with the treatment program of moderate intensity upper limb ergometer for 15 minute with frequency three times per week for four weeks.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Medicinal plants for the treatment and prevention of post-menopausal obesity: a review.
Liu J, Akter R, Rupa EJ, Van-An H, et al · · 2025 · cited 1× · PMID 40469982 · DOI 10.3389/fphar.2025.1564131

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04676074 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 8 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04676074.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing